Air Liquide combines defensive industrial gases cash flows with structural growth from electronics (semiconductor fab buildouts), healthcare (home oxygen), and hydrogen mobility/decarbonization investments. Take-or-pay contracts with electricity pass-through provide highly visible earnings. The advance toward 'molecule pure-play' from chemicals trading peers is widening valuation premia. Hydrogen JVs with major industrials are scaling commercially rather than remaining R&D.
Signals scoped to FR · Company-specific tagging coming soon.